Tuberculosis Elimination in the Asia-Pacific Region and the WHO Ethics Guidance.

Justin T Denholm, Diego S Silva, Erlina Burhan, Richard E Chaisson

Open access · goldAbstract read

In one paragraph

Article in Tropical medicine and infectious disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact, top 88% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 4 countries.

Justin T DenholmVictorian Tuberculosis Program, Melbourne Health, and Department of Microbiology and Immunology, University of Melbourne at the Doherty Institute, Melbourne 3000, Australia. justin.denholm@mh.org.au.ORCID 0000-0002-9214-6431

Diego S SilvaFaculty of Health Sciences, Simon Fraser University, Vancouver, BC V6B 5K3, Canada. diego_silva@sfu.ca.

Erlina BurhanDepartment of Pulmonology and Respiratory Medicine, Faculty of Medicine Universitas of Indonesia/Persahabatan Hospital, Jakarta 13230, Indonesia. erlina_burhan@yahoo.com.

Richard E ChaissonJohns Hopkins University Center for Tuberculosis Research, Baltimore, MD 21287, USA. rchaiss@jhmi.edu.

Johns Hopkins University · USSimon Fraser University · CAThe University of Melbourne · AUUniversity of Indonesia · ID

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026

$67.0M

NIAID NIH HHS P30 AI094189

6 · The paper itself

Abstract

The World Health Organization has produced ethical guidance on implementation of the End TB strategy, which must be considered in local context. The Asia-Pacific Region has important distinctive characteristics relevant to tuberculosis, and engagement with the ethical implications raised is essential. This paper highlights key ethical considerations for the tuberculosis elimination agenda in the Asia-Pacific Regions and suggests that further programmatic work is required to ensure such challenges are addressed in clinical and public health programs.

Indexed as

ethicspublic healthtuberculosisWorld Health Organization

Identifiers

PMID30384409

DOI10.3390/tropicalmed3040115

PMCPMC6306794

OpenAlexW2898849466

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.